Inhibitors of N-ethylmaleimide sensitive factor

Methods and compositions for blocking exocytosis by inhibition of proteins that regulate exocytosis, such as N-ethylmaleimide Sensitive Factor (NSF), are provided. The compositions include multidomain fusion peptides containing a domain that causes the fusion peptide to cross the cellular membrane (...

Full description

Saved in:
Bibliographic Details
Main Authors Lowenstein, Charles, Matsushita, Kenji, Morrell, Craig
Format Patent
LanguageEnglish
Published 22.03.2011
Online AccessGet full text

Cover

More Information
Summary:Methods and compositions for blocking exocytosis by inhibition of proteins that regulate exocytosis, such as N-ethylmaleimide Sensitive Factor (NSF), are provided. The compositions include multidomain fusion peptides containing a domain that causes the fusion peptide to cross the cellular membrane (e.g. a domain from the TAT protein of HIV) and a domain that inhibits NSF (e.g. a domain of NSF). Administration of the fusion peptide promotes anticoagulation, attenuates thrombosis, and decreases heart attack severity.